Gene Editing Service Market Growth Opportunities and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Gene Editing Service Market covers analysis By Technology ( Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nuclease (TALEN), Zinc Finger Nuclease (ZFN), Other Technologies ); Application ( Cell Line Editing, Animal Genome Editing, Plant Genome Editing, Others ); End-User ( Pharmaceutical Companies And Biotechnology Companies, Academics And Government Research Institutes, Clinical Research Organizations ) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Oct 2025
  • Report Code : TIPRE00008953
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150
Page Updated: Apr 2025

The Gene Editing Service Market is expected to register a CAGR of 10.4% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The Gene Editing Service Market report covers analysis by Technology (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nuclease (TALEN), Zinc Finger Nuclease (ZFN), Other Technologies); Application (Cell Line Editing, Animal Genome Editing, Plant Genome Editing, Others); End-User (Pharmaceutical Companies And Biotechnology Companies, Academics And Government Research Institutes, Clinical Research Organizations), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.

Purpose of the Report

The report Gene Editing Service Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Gene Editing Service Market Segmentation

Technology

  • Clustered Regularly Interspaced Short Palindromic Repeats
  • Transcription Activator-Like Effector Nuclease
  • Zinc Finger Nuclease

Application

  • Cell Line Editing
  • Animal Genome Editing
  • Plant Genome Editing

End-User

  • Pharmaceutical Companies And Biotechnology Companies
  • Academics And Government Research Institutes
  • Clinical Research Organizations

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Gene Editing Service Market: Strategic Insights

gene-editing-service-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Gene Editing Service Market Growth Drivers

  • Advances in CRISPR Technology: The introduction of CRISPR-Cas9 has revolutionized gene editing due to its simplicity, precision, and cost-effectiveness. This technology allows for more efficient gene modifications compared to older methods such as TALENs and ZFNs. CRISPR technology has gained widespread acceptance in research and therapy, driving demand for gene editing services. The continuous advancements and refinements in CRISPR technology, including CRISPR-based gene therapies, are fueling growth in the gene editing service market.
  • Increasing Demand for Precision Medicine: As health care moves towards precision medicine, there is an increasing need for gene editing to provide tailored treatments. Gene editing technologies are part of the therapies tailored to an individual's genetic makeup, especially in the treatment of genetic disorders like sickle cell anemia, cystic fibrosis, and Duchenne muscular dystrophy. This is what has increased the demand for gene editing services in clinical applications, including gene therapy and cell-based therapies.
  • Investments in Genetic Research and Biotechnology: Strong investment in genetic research and biotechnology is driving gene editing technologies and services. Today, research organizations, biotechnology companies, and pharmaceutical companies are also investing more in the exploration of gene editing prospects in gene therapy, oncology, and other inherited diseases. In June 2024, GenKOre from South Korea collaborated with Revvity from the United States to work on gene therapies for ocular disorders. GenKOre's TaRGET platform would be coupled with the vectors developed by Revvity to pursue in vivo gene editing for Leber Congenital Amaurosis 10 and Usher Syndrome Type 2A. The growth in private and public funding for genetic research is fostering the growth of the gene editing service market.

Gene Editing Service Market Future Trends

  • Integration of gene editing with stem cell therapy: One of the most significant trends in the gene editing service market is the integration of gene editing techniques with stem cell therapy. Gene editing can be used to modify stem cells before they are used in therapies for treating genetic diseases, cancer, and autoimmune disorders. Combining gene editing with stem cell-based treatments offers the potential for more effective, personalized treatments for a wide range of conditions, including genetic mutations and tissue regeneration.
  • Expansion in Agricultural Biotechnology: It plays a more dominant role in agricultural biotechnology today as it develops gene editing in application areas including improvement of crops, and pest and disease resistance. More and more genetically modified crops and livestock will come into use using gene editing services to further develop food security and nutritional enhancement besides reducing impacts on the environment. The urgent interest in developing a sustainable system for farming in this world demands a climate-resistance crop as one of the results of applying gene editing in this industry.
  • Use of Gene Editing in Disease Modeling: The demand for gene editing services to develop disease models in research applications is increasing. Researchers can achieve more precise models of human diseases by adding a specific genetic mutation to a laboratory animal. These models are crucial for drug development, toxicology testing, and disease mechanism studies. In May 2024, Merck KGaA (Germany) acquired Mirus Bio, Inc. (US), integrating Mirus Bio's transfection technology with Merck's bioprocessing expertise. This acquisition, completed enhanced Merck's capabilities in viral vector manufacturing, advancing support for cell and gene therapies. Thus, the rising demand for gene-edited models in pharmaceutical and biotechnological drug discovery and preclinical research is creating demand for gene-editing services.

Gene Editing Service Market Opportunities

  • Development of New Genomic Editing Instruments: Such developments will continue offering opportunities for building next-generation tools for genetic editing that are of higher precision and efficiency and can be safer for use. This will give such companies an upper hand in their endeavors when it comes to market competition. Agilent Technologies, Inc. in the United States acquired BIOVECTRA, Inc. (Canada) in July 2024. Its biopharma solutions were extended by the strength of BIOVECTRA's expertise in biologics and gene editing. Thus, Agilent's drug development and manufacturing capabilities would be expanded. Innovations in gene-editing tools are likely to break new grounds regarding safer and more efficient gene modifications; this will usher in new uses and further contribute to the expanding gene editing services market.
  • Strategic Partnerships and Collaborations: Collaboration between biotech firms, pharmaceutical companies, academic institutions, and research organizations presents a significant opportunity for expanding gene editing services. By partnering with leaders in drug development and clinical research, gene editing service providers can expand their reach, access new technologies, and participate in large-scale clinical trials. In March 2023, GenScript (US) announced a strategic collaboration with PersonGen-Anke Cellular Therapeutics (US) to advance cell isolation products. The collaboration aimed to enhance the efficiency of developing and producing cell therapy. GenScript's CytoSinct platform was expected to support PersonGen in reducing costs and improving R&D efficiency in cell therapy. Strategic partnerships can accelerate the development of new therapies and increase the market visibility of gene editing services.
  • Gene Editing for Agriculture and Food Security: The demand for sustainable food production methods is creating a strong opportunity for gene editing services in the agricultural sector. Gene editing can revolutionize food production systems by improving crop yields, resistance to pests, and environmental stress tolerance. Agricultural gene editing services that focus on genetically modified crops or livestock to meet the growing global demand for food are likely to experience significant market growth, particularly in regions facing food security challenges.

Gene Editing Service Market Regional Insights

The regional trends and factors influencing the Gene Editing Service Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Gene Editing Service Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Gene Editing Service Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 10.4%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Technology
  • Clustered Regularly Interspaced Short Palindromic Repeats
  • Transcription Activator-Like Effector Nuclease
  • Zinc Finger Nuclease
By Application
  • Cell Line Editing
  • Animal Genome Editing
  • Plant Genome Editing
By End-User
  • Pharmaceutical Companies And Biotechnology Companies
  • Academics And Government Research Institutes
  • Clinical Research Organizations
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • GenScript USA Inc.
  • Horizon Discovery Group plc
  • Integrated DNA Technologies Inc.
  • Lonza Group Ltd
  • Merck & Co.
  • New England Biolabs Inc.
  • Origene Technologies Inc.
  • Sangamo Biosciences Inc.
  • Thermo Fisher Scientific Inc.

  • Gene Editing Service Market Players Density: Understanding Its Impact on Business Dynamics

    The Gene Editing Service Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.


    gene-editing-service-market-cagr

    • Get the Gene Editing Service Market top key players overview

    Key Selling Points

    • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Gene Editing Service Market, providing a holistic landscape.
    • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
    • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
    • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

    The research report on the Gene Editing Service Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


    Frequently Asked Questions

    1
    What are the major driving factors impacting the Gene Editing Service Market?
    The major factors driving the Gene Editing Service Market are Advances in CRISPR Technology, Increasing Demand for Precision Medicine, and Investments in Genetic Research and Biotechnology.
    2
    What are the future trends of the Gene Editing Service Market?
    The key future trends of the market are Integration of gene editing with stem cell therapy, Expansion in Agricultural Biotechnology, and Use of Gene Editing in Disease Modeling.
    3
    Which are the leading players operating in the Gene Editing Service Market?
    The leading players operating in the Gene Editing Service Market include GenScript USA Inc., Horizon Discovery Group plc, Integrated DNA Technologies Inc., Lonza Group Ltd, Merck & Co., New England Biolabs Inc., Origene Technologies Inc., Sangamo Biosciences Inc., and Thermo Fisher Scientific Inc.
    4
    What are the deliverable formats of Gene Editing Service Market report?
    The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
    5
    What are the options available for the customization of this report?
    Some of the customization options available based on the request are an additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
    6
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can't access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    The List of Companies

    1. GenScript USA Inc.
    2. Horizon Discovery Group plc
    3. Integrated DNA Technologies Inc.
    4. Lonza Group Ltd
    5. Merck & Co.
    6. New England Biolabs Inc.
    7. Origene Technologies Inc.
    8. Sangamo Biosciences Inc.
    9. Thermo Fisher Scientific Inc.
    10. Transposagen Biopharmaceuticals Inc.

    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo